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Community Acquired Pneumonia 
 Pneumonia is a potentially dangerous lung condition that has a wide variety of causes.  
These causes usually include microorganisms, such as viruses, bacteria, fungi, and parasites.  
Pneumonia involves an infection in the parenchyma, including the alveoli and bronchioles, 
which makes breathing difficult.  In the healthcare field, pneumonia is often categorized by the 
location where the infection was contracted.  This helps to identify the most likely causes of the 
pneumonia in order to begin treatment.  The most common categories are community-acquired 
and medical care-associated pneumonia.  This paper will discuss community acquired 
pneumonia, including the pathophysiology, treatment, patient education, and nursing practice 
points. With proper diagnosis and education, community acquired pneumonia can result in a 
positive patient outcome. 
 A patient may be diagnosed with community-acquired pneumonia (CAP) if symptom 
onset has not occurred within 14 days of being in a medical care facility.  In the United States, 
CAP is the sixth leading cause of death in those over the age of 65.  This is often due to the 
decreased immune system that comes naturally with age.  The lower respiratory tract can usually 
defend against infection through mechanisms such as the cough reflex, epiglottal reflexes, and 
mucociliary escalator (Lewis et al., 2014).  The mucociliary escalator is performed by epithelial 
cells lining the respiratory tract.  These cells produce a layer of mucus, trapping particles 
attempting to enter the airway.  The cilia of the epithelium move this mucus in an upward motion 
until the mucus is either swallowed or coughed out.  If functioning normally, this process will 
help to remove organisms that could be potentially infectious (Grossman & Porth, 2014).  
However, with factors including aging, smoking, and loss of consciousness, this mechanism, as 
well as others, may be impaired.  Without these defenses, pathogens are more likely to enter the 
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lungs through aspiration of normal flora, inhalation, and hematogenous spread (Lewis et al., 
2014). 
 The direct effect of pathogens on the lungs depends on the specific cause.  However, 
most microorganisms infect the lung and induce an inflammatory response.  Inflammation 
normally occurs with two stages: vascular and cellular.  The vascular response involves 
vasodilation at the site of injury or infection.  As blood flow increases, vessels become more 
permeable, allowing protein to escape the intravascular space.  This release of fluids causes 
swelling and hemostasis.  With hemostasis and subsequent clotting, the body attempts to localize 
the infection and prevent further spread.  Additionally, with the second phase of inflammation, 
leukocytes are presented to the site of infection to kill the invading pathogens.  As blood flow 
slows from the vascular phase, leukocytes adhere to vessel walls.  Molecules called selectins aid 
the leukocytes, primarily neutrophils, in transmigrating through the vessel wall, then chemotaxis 
leads the cells to the infected area (Grossman & Porth, 2014).  When this normal inflammatory 
response occurs in the lungs, many problems can follow.  As blood vessels release fluid, it 
begins to fill the alveoli.  This process, known as consolidation, can be found through physical 
examination or diagnostic testing.  Consolidation can impair gas exchange within the alveoli, 
resulting in symptoms of hypoxia.  Furthermore, this is worsened with the production of excess 
mucus in the airway.  However, if macrophages can successfully remove the debris and restore 
lung tissue, gas exchange will normalize.  This may or may not occur, depending on the presence 
of complications during pneumonia treatment (Lewis et al., 2014).   
 Before starting treatment for pneumonia, it is important to acquire a proper diagnosis and 
discover the causative microbe.  Community-acquired pneumonia is most commonly caused by a 
bacteria called Streptococcus pneumoniae.  Common signs and symptoms may include chest 
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pain, productive cough, fatigue, fever, nausea or vomiting, and dyspnea.  Those older than 65 or 
younger than 2 years old should see a physician if pneumonia is suspected.  A diagnosis may be 
confirmed with a chest x-ray, blood test, sputum test, or pulse oximetry.  These tests allow the 
physician to asses for consolidation, oxygen levels, and the presence of a pathologic organism.  
Ultimately, treatment will depend on the type of pneumonia (Mayo Clinic, 2016).  As the cause 
of community-acquired pneumonia is bacterial in origin, once a culture has been taken, patients 
are given empiric antibiotic therapy.  This is given before reaching a definitive diagnosis to begin 
treating the infection immediately.  This often begins with a broad spectrum antibiotic, which 
will later be substituted with a narrow spectrum agent once the exact cause is identified (Lewis et 
al., 2014).   
 Empiric antibiotic therapy is dependent on previous risk factors, including comorbidities, 
likelihood of antibiotic resistance, and the location the patient is being treated.  The primary 
groups of antibiotics used are macrolides, fluoroquinolones, and β-lactams (Lewis et al., 2014).  
Macrolides are broad spectrum agents that impede bacterial protein synthesis.  The prototype 
drug, erythromycin, is effective against most gram positive bacteria, which are typically the 
cause of CAP.  It is generally a safe antibiotic, with some possible gastrointestinal side effects.  
However, there is a small risk of cardiotoxicity, especially with the use of antidysrhythmic drugs, 
such as quinidine.  Additionally, this drug interacts with warfarin, an anticoagulant, by 
increasing warfarin levels in the blood.  Warfarin is a regularly used drug, so use of 
erythromycin by a patient taking warfarin may require additional monitoring.  However, the 
second group of antibiotics, called fluoroquinolones, work differently.  These broad spectrum 
agents inhibit DNA synthesis and can be taken orally.  Additionally, fluoroquinolones are 
bactericidal, rather than bacteriostatic, directly resulting bacterial death.  While the prototype 
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drug for this groups of antibiotics is ciprofloxacin, levofloxacin is generally used for respiratory 
infections. All fluoroquinolones are generally well tolerated, but can cause some gastrointestinal 
effects and confusion.  However, there also exists a rare possibility of these drugs causing tendon 
rupture.  Risk factors for this side effect include taking glucocorticoids, being over 60 years of 
age, and having had a transplantation of the heart, lung, or kidney.  If this drug is prescribed, 
patients should avoid antacids or dairy products, as absorption will be inhibited.  Similarly to 
macrolides, fluoroquinolones have an adverse interaction with warfarin, which should be 
monitored closely in a patient taking these antibiotics (Burchum, Rosenthal, Jones, Neumiller, & 
Lehne, 2016). 
 Despite the effectiveness of macrolides and fluoroquinolones, the use of β-lactams in 
some patients may be warranted to treat CAP.  β-lactams are a broad antibiotic category that 
includes penicillins, cephalosporins and carbampenems.  These antibiotics are in the same 
category due to their similar mechanism of action.  They affect the cell wall of bacteria, either by 
inhibiting its synthesis or by directly weakening it.  Penicillins include a wide variety of narrow 
and broad spectrum agents, which have similar chemical properties.  When first discovered, 
penicillin was used widely to treat various diseases.  However, many bacteria have now 
developed resistance to the drugs, including methicillin-resistant Staphylococcus aureus 
(MRSA).  However, drugs like amoxicillin can still be used effectively to treat CAP.  One of the 
most common adverse effects of penicillins is hypersensitivity, which is fairly common.  For 
these patients, there is also a one percent chance of a cross-over hypersensitivity to 
cephalosporins.  Therefore, as a precaution, cephalosporins may not be used in those with a 
penicillin allergy.  Cephalosporins are composed of five generations, which increasingly improve 
treatment against gram negative bacteria, resistance to beta-lactamases, and the ability to cross 
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the blood-brain barrier.  Adverse effects usually include hypersensitivity, but can also include an 
effect on vitamin K metabolism.  Since vitamin K is essential for clotting factors, cephalosporins 
may cause bleeding disorders.  Lastly, carbampenems are the broadest spectrum of antibiotics.  
However, they can cause adverse gastrointestinal effects, hypersensitivity, and seizures.  
Imipenem and meropenem are examples that are used to treat CAP (Burchum et al., 2016).   
Overall, there are many options to treat CAP if caused by a bacterial infection.  Other 
treatments for community-acquired pneumonia include symptomatic care.  Antipyretics may be 
used to reduce fever, including acetaminophen and ibuprofen.  These drugs will also work to 
relieve pain which is present with pneumonia.  Cough suppressants can be used to achieve rest, if 
coughing is preventing a patient from sleeping.  However, a low dose should be used to prevent 
total removal of the cough reflex (Mayo Clinic, 2016).   
 In order to prevent community-acquired pneumonia, it is important to educate the patient 
before they actually acquire an infection.  This can include promotion of proper nutrition, rest, 
exercise, and hand hygiene.  These lifestyle choices lower the risk for acquiring an infection.  
Additionally, since a primary risk factor for CAP is smoking, healthcare professionals should 
encourage patients to avoid smoking if possible (Lewis et al., 2014).  Moreover, there are 
currently two vaccinations available that lower the incidence of pneumonia in patients at risk.  
These are the pneumococcal conjugate and pneumococcal polysaccharide vaccinations.  Both are 
recommended for adults older than 65, and those younger than 65 with medical conditions that 
place them at greater risk for acquiring pneumonia, including diabetes mellitus.  While the 
vaccines are not totally effective, they can greatly decrease the likelihood of acquiring CAP.  
Patients at risk should be educated on their options regarding this vaccination (Centers for 
Disease Control and Prevention, 2016).  However, if a patient has already contracted pneumonia, 
6
The Kabod, Vol. 3, Iss. 3 [2017], Art. 8
http://digitalcommons.liberty.edu/kabod/vol3/iss3/8
COMMUNITY ACQUIRED PNEUMONIA  7 
  
 
it is important to educate the patient on drug therapy and home care.  All antibiotic regimens 
must be completed in their entirety, or the patient may be at risk of acquiring a drug resistant 
infection.  Additionally, the patient should be informed of any drug or food interactions and how 
the medications are taken.  Pneumonia patients should also be taught about the importance of rest 
and fluid intake.  The patient should be drinking around 6-10 glasses of fluids daily.  Recovery 
may take weeks, and further diagnostic exams may be performed before the diagnosis is resolved 
(Lewis et al., 2014). 
 Along with patient education, the nurse plays an important role in directly treating 
patients with CAP.  One of the most important interventions for a nurse is to practice medical 
asepsis.  If proper medical asepsis is not used, including proper hand hygiene and glove use, 
infection can be spread from patient to patient.  As the patient with CAP already has a more 
compromised immune system, he or she may also be more vulnerable to further infections.  
Additionally, the patient with CAP may spread their infectious agent to other patients, therefore 
the nurse must be vigilant in protecting all patients with proper practice.  For the CAP patient, 
the nurse must administer appropriately prescribed medications.  This includes antibiotics, 
antipyretics, and analgesics to treat both the patient’s infection and symptoms.  Additionally, it is 
important that while the patient is in the hospital, proper fluid intake is encouraged.  Fluids can 
help mobilize secretions that are building up in the patient’s airway.  For this same reason, to the 
individual patient’s ability, activity should be encouraged.  If the patient’s pneumonia is 
unilateral, then the patient should remain in a side lying position, with the unaffected lung facing 
downward.  Ultimately, most nursing interventions will improve mobilization of secretions and 
treat symptoms (Lewis et al., 2014).  
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 Overall, community acquired pneumonia normally has a good prognosis.  Some patients 
may experience improvement in as little as 2 weeks.  Patients that are young, 
immunocompromised or elderly may have a more different period of recovery.  Many 
complications can come from community acquired pneumonia, including pleural effusion, 
empyema, and lung abscesses.  In the worst cases, pneumonia may result in death.  However, 
with proper treatment, most patients with community-acquired pneumonia can make a full 
recovery (Hadjiliadis, 2015).  Therefore, healthcare professionals providing the patient with 
education and proper treatment is critical to their prognosis.  In conclusion, while community 
acquired pneumonia can be a dangerous respiratory condition, proper treatment and education 
may result in a positive prognosis. 
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